BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
8 hedge funds and large institutions have $6.02M invested in BriaCell Therapeutics Corp Warrant in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
60% more funds holding
Funds holding: 5 → 8 (+3)
30% more capital invested
Capital invested by funds: $4.64M → $6.02M (+$1.39M)
0.97% more ownership
Funds ownership: 6.56% → 7.54% (+0.97%)
87% less call options, than puts
Call options by funds: $1.16M | Put options by funds: $9.21M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$309K |
| 2 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$179K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$64.1K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$63.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.53K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
M
1
Murchinson
Toronto,
Ontario, Canada
| $2.44M | +$309K | +77,738 | +20% |
|
|
AC
2
Armistice Capital
New York
| $1.95M | – | – | – |
|
|
KJHP
3
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| $832K | +$179K | +44,910 | +39% |
|
|
RAM
4
Redmond Asset Management
Henrico,
Virginia
| $390K | – | – | – |
|
|
ZCA
5
Zeke Capital Advisors
Berwyn,
Pennsylvania
| $234K | – | – | – |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $84K | +$64.1K | +16,092 | New |
|
|
WAM
7
Warberg Asset Management
Winnetka,
Illinois
| $83K | +$63.9K | +16,046 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $6K | +$4.53K | +1,137 | New |
|
BCTXW Hedge Fund Activity: Q1 2022 in Review
8 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q1 2022, worth a combined $6.02M — up 30% from $4.64M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BCTXW positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Murchinson, adding an estimated $309K.
- 8 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q1 2022, up from 5 in Q4 2021.
- Funds reported $6.02M of BriaCell Therapeutics Corp Warrant stock for Q1 2022, up 30% quarter-over-quarter.
- 3 funds opened new BriaCell Therapeutics Corp Warrant positions in Q1 2022 and 0 closed out, a net change of +3 holders.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q1 2022 was Murchinson, an estimated $309K added.
Based on aggregated 13F filings for Q1 2022.